Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News

Muscle Is the Longevity Asset Most People Ignore

by Team Lumida
February 26, 2026
in News
Reading Time: 3 mins read
A A
0
topless man with black background

Photo by Nigel Msipa on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key takeaways

Powered by lumidawealth.com

  • Higher muscle mass and strength are strongly associated with lower all-cause mortality.
  • Muscle improves glucose control, insulin sensitivity, and metabolic flexibility.
  • Age-related muscle loss (sarcopenia) accelerates frailty, falls, and chronic disease risk.
  • Resistance training and adequate protein intake are among the most effective longevity interventions.

What Happened?

Longevity science increasingly highlights skeletal muscle as more than a mobility tissue—it functions as a metabolic organ. Research shows that individuals with greater grip strength and lean muscle mass have significantly lower risks of cardiovascular disease, type 2 diabetes, and premature death. At the same time, age-related muscle decline begins as early as the 30s and accelerates after 60, reducing functional capacity and increasing vulnerability to illness and injury.

Why It Matters?

Muscle directly regulates glucose disposal and insulin sensitivity, acting as a large reservoir for circulating sugar. More muscle means better metabolic stability, lower inflammatory burden, and greater resilience during acute stressors such as infections or hospitalization. In aging populations, preserving muscle mass reduces fall risk, supports independence, and lowers healthcare utilization. From a cost-benefit perspective, resistance training offers one of the highest returns per hour invested compared with many medical interventions.

What’s Next?

Expect greater integration of strength metrics—such as grip strength and lean mass scans—into preventive health frameworks. Watch for growing emphasis on protein optimization (especially in older adults), structured resistance training, and metabolic monitoring as mainstream longevity strategies. The long-term opportunity lies in shifting from reactive healthcare to proactive muscle preservation as a foundational pillar of healthy aging.

Previous Post

Tariff Volatility Accelerates Africa’s Shift Away From the Dollar, Ecobank Warns

Next Post

Paramount Wins Warner Discovery After Netflix Walks—A $81B Media Megamerger Takes Shape

Recommended For You

AbbVie Beats by 9 Cents as Immunology Sales Jump 16% to $9.17 Billion, Lifting Its Profit Outlook and Raising Its Dividend 5.2% to $1.82

by Team Lumida
2 days ago

AbbVie’s Q3 revenue rose 10% to $17.4 billion on Skyrizi and Rinvoq, and it raised full-year guidance above Wall Street’s forecast.

Read more

SoftBank-Backed OPay Prices Its NYSE IPO at the Bottom of Its Range at $19 a Share, Valuing the Nigerian Fintech at About $4 Billion

by Team Lumida
2 days ago

OPay sold 16 million ADSs at $19, the low end of its $19 to $21 range, for a roughly $4 billion valuation ahead of its NYSE debut on...

Read more

US Labor Costs Trail Inflation for a Second Straight Quarter, as Wage Growth Slows to 3.1%, the Lowest Since 2021, and Health Benefit Costs Jump 6.4%

by Team Lumida
2 days ago

The employment cost index rose 3.4% in the year through September but fell 0.4% after inflation, with real wages down 0.6%.

Read more

US Treasury Borrows a Record $839 Billion in One Week of Auctions, but Only $106 Billion Is New Money as Rolling Over Maturing Bills Dominates

by Team Lumida
2 days ago
Treasury Sells $22 Billion of 30-Year Debt and Buys Back Up to $6 Billion of the Same Sector the Same Day

The US sold a record $839 billion of bills and notes this week, topping $834 billion a year ago, as rolling over maturing debt drives auction sizes.

Read more

Fed’s Barkin Backs ‘Gradual’ Rate Hikes, Saying the Direction Is Clear but the Pace Is the Question, and Warns an AI Investment Surge May Need Leaning Against

by Team Lumida
2 days ago

Richmond Fed President Tom Barkin said gradual hikes make sense with inflation high, unemployment low and AI-driven demand still strong.

Read more

Investors Flee Tech for Defensives: Consumer Staples ETF Hits a Record and Health Care a 52-Week High, While Gold Sinks to Its Lowest Since November 2025

by Team Lumida
2 days ago

As the Nasdaq fell over 2%, money moved into staples and health care, with XLP at a record high, while gold and silver hit near one-year lows.

Read more

BofA Downgrades Intel as Five Firms Cut Price Targets After Its Guidance Miss, While Jefferies Upgrades Rivian and Morgan Stanley Keeps Amazon as a Top Pick

by Team Lumida
2 days ago

BofA cut Intel to neutral as four other firms slashed targets, while Jefferies upgraded Rivian and HSBC lifted GE Vernova to buy on Friday.

Read more

BofA’s Hartnett Says Buy Big Tech Bonds, Not Stocks, as Hyperscaler Debt Yields 6% to 8% and Meta’s $95 Billion Stock Sale Signals the End of the Buyback Era

by Team Lumida
2 days ago

BofA’s Michael Hartnett calls Magnificent Seven bonds yielding 6% to 8% ‘diamonds in the rough’ as AI spending drains cash and Meta sells stock.

Read more

Election Odds on Kalshi and Polymarket Can Be Moved Cheaply: 88% of 18,000 Congressional Markets Could Swing 10 Cents on a Single Bet Under $1,000

by Team Lumida
2 days ago

A CNBC review with ACDC found 23% of big congressional markets saw 30-cent price spikes, raising manipulation fears days before the midterms.

Read more

Wall Street Braces for Democratic Gains: 96% of Investors in a Wolfe Survey Expect a Democratic House, and Piper Sandler Says Democrats’ Plans Would Add $5 Trillion to the Deficit

by Team Lumida
2 days ago

Analysts expect Democrats to win the House on Tuesday and see the Senate as close, setting up gridlock and a debt-ceiling fight in 2027.

Read more
Next Post
white and black concrete building during night time

Paramount Wins Warner Discovery After Netflix Walks—A $81B Media Megamerger Takes Shape

Pentagon–Anthropic Feud Escalates as AI Policy Clash Threatens Defense Contracts

Anthropic Defies Pentagon on AI Guardrails, Raising Stakes for Defense Tech Policy

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Warren, Sanders Warn PE and Crypto in 401(k)s Could Harm Savers

Warren, Sanders Warn PE and Crypto in 401(k)s Could Harm Savers

October 30, 2025
China’s Financial Overhaul: Xi’s Strategy to Rebalance $9.1 Trillion Debt Crisis

U.S. Risks Losing Biotech Leadership to China, Congressional Commission Warns

April 8, 2025
Oracle’s Q4 earnings missed expectations but stock jumped ~11% after new cloud deals

Oracle’s AI Buildout Puts Its Bonds in the Crosshairs as Debt and Lease Commitments Surge

December 16, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018